Daniel Victor Ortigoza: Understanding Stroke, Risk Factors and Prevention
Daniel Victor Ortigoza, Vicepresidente del Comité de Cardio Oncología de FAC at Federación Argentina de Cardiología, shared a post on LinkedIn about recent articles:
“Stroke Week
Stroke is caused by the cessation of vascular flow in the central nervous system or by hemorrhage of the system and, or the membranes surrounding it, resulting in tissue damage.
Stroke is classified as: Ischemic stroke, which accounts for 62percent of cases, and Hemorrhagic stroke, the remaining 38percent. The latter is divided into: Intracranial hemorrhagic (28percent) and subarachnoid (10percent).
Based on the etiological classification of TOAST (Trial of Org 10172 in Acute Stroke Treatment), ischemic strokes can be classified into 5 groups:
- Stroke due to a Cardioembolic event (27percent), secondary to Atrial Fibrillation or Flutter;
- Cryptogenic stroke (35percent), of unknown etiology, whose most frequent causes are: diseased atria, non significant atherosclerotic plaques, aortic calcifications, procoagulant states of cancer, etc.;
- Apoplexy due to arteriosclerosis of large vessels (13percent) corresponding to the carotid, vertebral, basilar and cerebral arteries;
- Small vessel stroke (23percent) caused by poor control of arterial hypertension, and finally;
- Stroke of other determined etiologies (4percent), of very diverse origins: mayamoya disease, antiphospholipid syndrome, congenital heart disease, etc.
Due to the increasing aging of the population, an increase in the incidence of stroke is expected in the coming decades, so it is necessary to carry out rigorous controls of the risk factors (high blood pressure, diabetes mellitus, obesity, dyslipidemia, smoking, among others), and in this way be able to reduce the recurrences of stroke and major cardiovascular events.
With the use of antiplatelet agents and in specific cases of primary and secondary prevention of Cardioembolic Stroke due to Atrial Fibrillation, anticoagulation (direct acting anticoagulants) is recommended, except in rare exceptions.
Author: Dr. Ortigoza Daniel Víctor.
References:
- Antonio Greco, MD, et al. Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke JACC State of the Art Review. J Am Coll Cardiol 2023;
- Jan Steffel et al. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace (2021) 23, 1612 to 1676.
- Daniel Ortigoza. Fibrilación Auricular: nueva Guía y Recomendaciones en situaciones particulares. ElectroSIAC, mayo 2024.”
Title 1: Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State of the Art Review
Authors: Antonio Greco, Giovanni Occhipinti, Daniele Giacoppo, Federica Agnello, Claudio Laudani, Marco Spagnolo, Maria Sara Mauro, Carla Rochira, Simone Finocchiaro, Placido Maria Mazzone, Denise Cristiana Faro, Davide Landolina, Nicola Ammirabile, Antonino Imbesi, Carmelo Raffo, and Davide Capodanno
Read the Full Article on JACC Journal.
Title 2: 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Authors: Jan Steffel, Ronan Collins, Matthias Antz, Pieter Cornu, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, Peter Sinnaeve, Thomas Vanassche, Tatjana Potpara, A John Camm, Hein Heidbüchel
Read the Full Article on EP Europace.
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 22, 2026, 14:39Mahmoud Abdelnabi: Evaluating the Evidence on Elevated Lp(a) and VTE Before Clinical Translation
-
Oct 22, 2026, 14:34David McIntosh: Fundamental Flaws in National Blood Systems Are Root Causes of Failure
-
Oct 22, 2026, 14:32Aurelio Maggio: Bridging Scientific Progress and Equitable Access to SCD Care in Sub-Saharan Africa
-
Oct 22, 2026, 14:26Khaled Musallam: Longevity and Healthy Aging in Thalassemia
-
Oct 22, 2026, 14:26Deise Catamo Vaz: Two Years of Growth and a New Way of Seeing the World of Stroke
-
Oct 22, 2026, 14:24Yara Mohamed: A Silent Killer Plots his Victim’s Death Over Years
-
Oct 22, 2026, 14:19Shailendra Singh: Two Different Pulmonary Embolism Cases, One Critically Important Lesson
-
Oct 22, 2026, 14:14Caitlin Raymond: Estimating Infection Rates After Therapeutic Plasma Exchange in a Large Real-World Population
-
Oct 22, 2026, 14:11Lesley Van Wyk: The Bombay Blood Group Explained